AdaptHealth Corp. (NASDAQ:AHCO) Shares Acquired by Segall Bryant & Hamill LLC

Segall Bryant & Hamill LLC raised its position in AdaptHealth Corp. (NASDAQ:AHCO - Free Report) by 29.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,803,981 shares of the company's stock after buying an additional 1,102,173 shares during the quarter. Segall Bryant & Hamill LLC owned approximately 3.57% of AdaptHealth worth $45,734,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also modified their holdings of the company. Pacer Advisors Inc. acquired a new stake in AdaptHealth during the 4th quarter worth $76,271,000. FMR LLC boosted its stake in shares of AdaptHealth by 9.3% during the third quarter. FMR LLC now owns 7,350,549 shares of the company's stock worth $82,547,000 after buying an additional 624,645 shares during the period. Reinhart Partners LLC. grew its holdings in shares of AdaptHealth by 1.1% during the fourth quarter. Reinhart Partners LLC. now owns 6,266,854 shares of the company's stock worth $59,660,000 after buying an additional 68,212 shares during the last quarter. State Street Corp increased its position in AdaptHealth by 19.8% in the 3rd quarter. State Street Corp now owns 4,124,284 shares of the company's stock valued at $46,316,000 after acquiring an additional 681,816 shares during the period. Finally, Geode Capital Management LLC raised its stake in AdaptHealth by 12.2% during the 3rd quarter. Geode Capital Management LLC now owns 2,451,173 shares of the company's stock valued at $27,532,000 after acquiring an additional 265,712 shares during the last quarter. 82.67% of the stock is owned by institutional investors and hedge funds.

AdaptHealth Price Performance

Shares of AHCO stock remained flat at $10.64 during midday trading on Friday. 856,018 shares of the stock were exchanged, compared to its average volume of 1,191,536. The business's fifty day moving average price is $10.02 and its 200 day moving average price is $10.17. The stock has a market cap of $1.43 billion, a price-to-earnings ratio of -6.45, a PEG ratio of 1.08 and a beta of 1.30. The company has a current ratio of 1.24, a quick ratio of 1.00 and a debt-to-equity ratio of 1.34. AdaptHealth Corp. has a 52 week low of $8.35 and a 52 week high of $11.90.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on the company. UBS Group dropped their target price on AdaptHealth from $12.00 to $11.00 and set a "buy" rating on the stock in a report on Thursday, February 13th. Robert W. Baird upped their price objective on shares of AdaptHealth from $14.00 to $16.00 and gave the stock an "outperform" rating in a research report on Thursday, February 27th. Truist Financial boosted their price target on shares of AdaptHealth from $12.00 to $14.00 and gave the stock a "buy" rating in a research note on Wednesday, February 26th. Royal Bank of Canada raised their price objective on shares of AdaptHealth from $11.00 to $14.00 and gave the company an "outperform" rating in a research report on Wednesday, February 26th. Finally, Canaccord Genuity Group boosted their target price on AdaptHealth from $13.00 to $14.00 and gave the stock a "buy" rating in a research report on Wednesday, February 26th. Five investment analysts have rated the stock with a buy rating, According to data from MarketBeat, AdaptHealth currently has an average rating of "Buy" and an average target price of $13.80.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.